Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient

Author:

Baang Ji Hoon1,Smith Christopher2,Mirabelli Carmen3,Valesano Andrew L13,Manthei David M4,Bachman Michael A4ORCID,Wobus Christiane E3,Adams Michael2,Washer Laraine1,Martin Emily T5,Lauring Adam S13

Affiliation:

1. Division of Infectious Diseases, University of Michigan, Ann Arbor, Michigan, USA

2. Division of Hospital Medicine, University of Michigan, Ann Arbor, Michigan, USA

3. Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA

4. Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA

5. Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA

Abstract

Abstract We describe a case of chronic coronavirus disease 2019 (COVID-19) in a patient with lymphoma and associated B-cell immunodeficiency. Viral cultures and sequence analysis demonstrate ongoing replication of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for at least 119 days. The patient had 3 admissions related to COVID-19 over a 4-month period and was treated twice with remdesivir and convalescent plasma with resolution of symptoms. The patient’s lack of seroconversion and prolonged course illustrate the importance of humoral immunity in resolving SARS-CoV-2 infection. This case highlights challenges in managing immunocompromised hosts, who may act as persistent shedders and sources of transmission.

Funder

University of Michigan

Centers for Disease Control and Prevention

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Reference14 articles.

1. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review;Wiersinga;JAMA,2020

2. Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients [manuscript published online ahead of print 19 August 2020];Xiao;Clin Infect Dis,2020

3. Predicting infectious SARS-CoV-2 from diagnostic samples [manuscript published online ahead of print 22 May 2020];Bullard;Clin Infect Dis,2020

4. Duration of SARS-CoV-2 infectivity: when is it safe to discontinue isolation;Rhee;Clin Infect Dis,2020

5. Within host RNA virus persistence: mechanisms and consequences;Randall;Curr Opin Virol,2017

Cited by 241 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3